| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2864871 | The American Journal of the Medical Sciences | 2009 | 4 Pages |
Abstract
CKD and hemodialysis patients receiving treatment with ESAs have significantly greater Hgb variability than patients with CKD not receiving ESAs. This finding suggests that the current practice pattern for the administration of exogenous ESAs is partly responsible for the observed Hgb variability.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
David M. MD,